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ABSTRACT
Objective Psychosocial and economic (socioeconomic) 
barriers, including poverty, stigma and catastrophic costs, 
impede access to tuberculosis (TB) services in low- income 
countries. We aimed to characterise the socioeconomic 
barriers and facilitators of accessing TB services in Nepal 
to inform the design of a locally appropriate socioeconomic 
support intervention for TB- affected households.
Design From August 2018 to July 2019, we conducted an 
exploratory qualitative study consisting of semistructured 
focus group discussions (FGDs) with purposively selected 
multisectoral stakeholders. The data were managed in 
NVivo V.12, coded by consensus and analysed thematically.
Setting The study was conducted in four districts, 
Makwanpur, Chitwan, Dhanusha and Mahottari, which 
have a high prevalence of poverty and TB.
Participants Seven FGDs were conducted with 54 in- 
country stakeholders, grouped by stakeholders, including 
people with TB (n=21), community stakeholders (n=13) 
and multidisciplinary TB healthcare professionals (n=20) 
from the National TB Programme.
Results The perceived socioeconomic barriers to 
accessing TB services were: inadequate TB knowledge 
and advocacy; high food and transportation costs; income 
loss and stigma. The perceived facilitators to accessing 
TB care and services were: enhanced championing and 
awareness- raising about TB and TB services; social 
protection including health insurance; cash, vouchers and/
or nutritional allowance to cover food and travel costs; 
and psychosocial support and counselling integrated 
with existing adherence counselling from the National TB 
Programme.
Conclusion These results suggest that support 
interventions that integrate TB education, psychosocial 
counselling and expand on existing cash transfer schemes 
would be locally appropriate and could address the 
socioeconomic barriers to accessing and engaging with 
TB services faced by TB- affected households in Nepal. 
The findings have been used to inform the design of 
a socioeconomic support intervention for TB- affected 
households. The acceptability, feasibility and impact 
of this intervention on TB- related costs, stigma and TB 
treatment outcomes, is now being evaluated in a pilot 
implementation study in Nepal.
BACKGROUND
Tuberculosis (TB) kills 1.3 million people 
each year worldwide, more than any other 
single infectious disease including, up to 
the time of writing, COVID- 19.1 In 2019, 
an estimated 10 million became ill with TB, 
of whom 2.9 million were not notified or 
remained undiagnosed and untreated.1 In 
low- income and middle- income countries 
(LMICs), stigma, marginalisation and cata-
strophic costs of accessing TB diagnosis and 
Strengths and limitations of this study
 ► The focus group discussions contributed to new 
knowledge on optimal local strategies to mitigate 
the socioeconomic impact of tuberculosis (TB).
 ► The evidence has directly informed the design of a 
novel socioeconomic support intervention for TB- 
affected households, which is undergoing pilot eval-
uation in Nepal.
 ► The credibility and trustworthiness of the study was 
maintained through member checking, using multi-
ple coders, conducting a consensus- based coding, 
recruiting local interviewers for data collection, per-
forming triangulation and including a broad selec-
tion of multidisciplinary stakeholders to inform the 
study conclusion.
 ► The study was conducted in four districts of Nepal, 
mostly lowland ‘plains’ districts, which could affect 
the transferability of the findings.
 ► People who were diagnosed with TB in private sec-
tors or those lost to follow- up did not participate in 
the study despite, in other settings, having been 
shown to be groups at high risk of severe socioeco-
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care, coupled with limited social protection coverage, 
can delay diagnosis, decrease TB treatment success rates 
and push TB- affected households into further impover-
ishment.2 3 To address this and move towards TB elimi-
nation, the WHO’s (WHO) 2015 End TB Strategy set the 
bold target that ‘Zero TB- affected families should face 
catastrophic costs’ and that psychosocial and economic 
(socioeconomic) support should be provided to TB- af-
fected people.4
Nepal is an LMIC in South Asia with significant TB inci-
dence (annual incidence 245/100 000) and mortality.5 
Despite free basic TB diagnostic tests, medicines and 
financial support for people with drug- resistant (DR- TB), 
approximately one in two people with TB face catastrophic 
costs (defined as the total TB- related costs equivalent to 
greater than 20% of a household’s annual income) while 
accessing TB care in Nepal.6 7 Such costs include travel 
for directly observed treatment short- course (DOTS), 
additional food expenditure and lost income, which can 
contribute to adverse TB treatment outcomes, especially 
for the poorest, most vulnerable households.6 8–10
The Nepal National TB Programme (NTP) provides 
NPR3000 (~US$27) in cash incentives monthly for 
transportation and nutritional support to people with 
multidrug- resistant TB (MDR- TB)11 who are enrolled 
in government treatment centres and receiving ambula-
tory care. There is currently no cash incentive scheme 
for people with drug- sensitive TB (DS- TB) in Nepal.12 
In other settings, socioeconomic support for TB- affected 
households, including mutual support groups and cash 
transfers, has been shown to help overcome barriers to 
accessing TB services, defraying catastrophic costs and 
improving treatment success rates.3 13–16 However, there 
is limited context- specific understanding of the barriers 
and facilitators to TB diagnosis and care in LMICs with 
which to inform the development of tailored socioeco-
nomic support interventions for people with TB and their 




We conducted an exploratory qualitative study, which used 
semistructured focus group discussions (FGDs) to collate 
the perceptions of key stakeholders in Nepal regarding 
socioeconomic barriers and facilitators of accessing and 
engaging with TB diagnosis and care. The study formed 
part of a larger programme of mixed- methods research17 
to design a locally appropriate socioeconomic support 
intervention for TB- affected households. The study 
adhered to the COnsolidated criteria for REporting Qual-
itative research (COREQ) Checklist.18
Study setting
The study was conducted in four districts of Nepal 
where Birat Nepal Medical Trust (BNMT), a Nepalese 
organisation with a focus on TB- related implementation 
research, implemented IMPACT- TB project. The 
districts: Makwanpur, Chitwan, Dhanusha and Mahottari 
have a high prevalence of poverty and TB (figure 1).11 
Makwanpur is a hilly district with limited road networks. 
Other three districts are lowland plains and challenged 
by high population density, poor health indicators and 
high rates of illiteracy.
Sampling
A desk- based scoping exercise was initially performed by 
team members (KD, RD and TW) to identify participants 
from relevant stakeholder groups in Nepal. To collate 
diverse perspectives on barriers and facilitators of TB 
diagnosis and treatment, the team purposively selected 
participants who had direct or indirect experiences with 
TB services. The participants included: people affected 
by TB who were currently receiving or had recently 
completed DS- TB or MDR- TB treatment with the NTP 
(referred to as ‘people with TB’ in the study); commu-
nity leaders such as female community health volunteers, 
teachers and social leaders from civil society organisa-
tions (CSOs, referred to as ‘community stakeholders’); 
and TB healthcare professionals, including those working 
with the NTP, community volunteers and TB- focused 
non- governmental organizations (NGOs) (referred to as 
‘NTP stakeholders’) (table 1). The list of people with TB, 
including their demographics, were gathered from the 
Figure 1 The highlighted colour represents the study 
districts in Nepal. Dhanusha, Mahottari and Chitwan are 
‘plains’ or ‘Terai’ districts. Makwanpur is a hilly district. 
The district’s data for population numbers and TB case 
notification rate highlight the burden of tuberculosis in each 
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Table 1 List of FGD stakeholder groups and participants
Stakeholder group Sex Age group (years) District Total no of participants




Female Under 20 Makwanpur
Male 30–35 Chitwan
Male 55–60 Chitwan
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IMPACT TB database or registers of the health clinics in 
each district. Community stakeholders were community 
leaders or those working in civil society and were selected 
based on their in- depth knowledge on the local context 
and experiences of working with the communities, pref-
erable in health progammes. TB healthcare professionals, 
such as those working with the NTP or TB- focused NGOs, 
have several years’ experience in planning, designing 
and implementing NTP activities. Community volunteers 
or mobilisers were people working with the IMPACT- TB 
project, who have first- hand experiences in screening 
symptoms of TB and supporting people with TB to 
adhere to and complete their treatment. These partici-
pants were selected based on the expertise in delivering 
community programmes and to bring diverse perception 
of the stakeholders into the study. Using telephone, email 
or in- person meetings, we invited 55 individuals to partic-
ipate in the study. Inclusion criteria were being 18 years 
of age or older and being able to give informed consent. 
Seven participants were invited to each of the seven FGDs 
with the exception of the TB healthcare professional 
FGD, which consisted of 12 participants. This related to 
the logistical challenges of organising more than one 
FGD with this group due to their working hours and time 
constraints coupled with the aim of representation from 
the public, private and NGO sectors of TB healthcare.
Data collection
The study team consisted of diverse members from 
multiple sectors including a physician, senior TB 
researchers, social scientists, public health professionals 
and project managers. An interview guide was developed 
by the coauthors with previous qualitative methods expe-
rience: TW (male, principal investigator, TB researcher), 
KD (female, doctoral student, project manager) and BR 
(male, public health specialist, research associate); BR 
and KD are employed by BNMT. The interview guide 
consisted of open- ended questions to explore the percep-
tions of participants concerning protective factors and 
risk factors for exposure to TB and development of TB 
disease; barriers and facilitators to accessing and engaging 
with TB diagnosis and care, including the recommenda-
tions for better access and engagement with TB diagnosis 
and care; and the socioeconomic impact on people with 
TB of being ill with the disease.
Prior to conducting FGDs, participants were provided 
with a ‘Participant Information Sheet’ that explained the 
purpose of the study, benefit and harm, and confiden-
tiality.17 Participants were provided time as they would 
require to read and understand the information in the 
paper and then decide if they are willing to participate 
in the study. The FGDs were conducted in a local hotel 
accessible to participants in the study districts. The topic 
guide was piloted with a group of seven female and male 
participants with TB resulting in minor refinements to 
the FGD structure and delivery techniques. TW moder-
ated the FGD with TB healthcare professional and KD 
and BR moderated the other six FGDs. Apart from these 
researchers, district field staff who supported patients 
attended the discussions and facilitated any dialectic 
interpretation or contextual explanations related to 
access to and engagement with TB services.
We conducted seven FGDs with 54 participants, which 
the project team perceived as giving sufficient informa-
tion power for the study.19 Of the participants, three- 
quarters were male and the average age was 42 years 
(table 1). To encourage an environment in which partic-
ipants felt comfortable and able to share their opinions 
and to balance gender representation, two of these FGDs 
were specifically for females with DS- TB and female TB 
community mobilisers. In all the FGDs, there were seven 
participants, except for the FGD with community leaders 
(n=6), FGD with TB healthcare professionals (n=12) and 
Stakeholder group Sex Age group (years) District Total no of participants
Male 55–60 Kathmandu
Male 45–50 Kathmandu
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FGD with community mobilisers (n=8). One invitee from 
the community leader’s FGD declined to participate due 
to lack of time. One additional community mobiliser 
showed interest to participate in the FGD with community 
mobilisers’ and was also included. We did not conduct any 
follow- up discussions with participants but some of the 
participants attended a workshop to discuss the FGD find-
ings, the outputs of which are published elsewhere.12 We 
performed real- time member checking in each FGD by 
noting key points of the discussion, summarising them on 
a wall chart and clarifying their accuracy with the group. 
No formal field notes were taken. The FGDs, which lasted 
90–120 min, were all conducted in Nepali language apart 
from the FGD with TB healthcare professionals, which 
was conducted in English. FGDs were audiorecorded, 
translated into English from Nepali language and back- 
translated by an independent translator who was not part 
of the project team. Each FGD was concluded when the 
facilitators collectively felt the topics in the FGD interview 
guide were sufficiently explored.
Analysis
We applied thematic analysis using NVivo V.12 to manage 
the data.20 The study used multiple coders, KD and TW, 
who familiarised themselves with the data through succes-
sive reading of transcripts. KD and TW separately gener-
ated the initial codes for each transcript before discussing 
and comparing the perception of understanding of the 
codes. The codes were updated through regular discus-
sion as further data became available and collated 
following each successive FGD. To increase trustworthi-
ness of the study, after all the transcripts were coded and 
analysed, KD and TW independently reviewed coding 
and themes and refined them through further discus-
sion, triangulation and consensus where necessary.21 Both 
open and closed first- order categories were used to label 
data. Categories were then grouped into second- order 
and third- order themes (online supplemental file 1). 
Table 2 shows an example of the analysis process of codes 
and themes. To better inform the design and delivery of 
the socioeconomic intervention for TB- affected house-
holds within the wider context of health services delivery, 
the first- order themes were then mapped to four levels of 
an adapted WHO Treatment Adherence Framework: (1) 
TB, health and basic education; (2) social protection and 
nutrition; (3) psychosocial and (4) healthcare system, TB 
diagnosis and care delivery.22 We chose to structure our 
analysis on the themes mapped to levels 1–4 of the WHO 
Framework because these levels were the most relevant 
to the study’s aim of informing design and development 
of a socioeconomic support intervention for TB- affected 
households. While important, themes identified that 
mapped to category IV of the Framework, such as govern-
mental policy, political commitment, public–private mix 
and healthcare infrastructure were perceived by the study 
team to be largely unmodifiable by a household- level 
socioeconomic support intervention. These themes are 
reported under health system categories and are shown 
in online supplemental file 2.
The study protocol is provided in online supplemental 
file 3. Written consent was obtained from all participants. 
Confidentiality of the participants was maintained by 
anonymising FGD responses, keeping any paper data in a 
locked cabinet at BNMT’s office and securing the data in 
a password- protected database.
Patient and public involvement
Patient and/or the public were not involved in the design 
or conduct of this research.
RESULTS
Overall, 36 codes related to eight themes were identified 
(online supplemental file 1). Below, we focus only on the 
perceived barriers and facilitators that mapped to catego-
ries: (1) TB, health and basic education, (2) social protec-
tion and nutrition and (3) psychosocial, of the adapted 
WHO Framework. These barriers and facilitators are 
shown in figure 2.
TB, health and basic education
Theme: information barrier to access and adhere to TB diagnosis 
and treatment
Across FGDs, we identified low literacy and education 
about TB as a barrier to accessing TB diagnosis and 
engaging with TB treatment (figure 2). Knowledge about 
TB including transmission, prevention, symptoms how 
and where to get diagnosed, treatment regimens and 
Table 2 An example of coding from the FGDs
FGD Quote
First- order 
category* Second- order themes Third- order themes
People diagnosed 
with TB
FGD with people diagnosed with 
TB, 30–35 years age group, male: 
‘People get criticized for having 
TB. The community perceives a TB 
patient isn’t the same as a normal 
person…. due to lack of awareness.’
Psychosocial  ► Enacted stigma
 ► Perceived stigma
 ► Lack of knowledge
Stigma as social 
barrier to access
*Adapted from a WHO Medication Adherence Framework.22
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duration, and the TB services available at health facilities 
were perceived to be limited, especially among illiterate 
and underserved groups or rural populations. A female 
participant with TB said: ‘I didn’t know that TB medicines 
were free in hospitals. I knew it only when I visited the health 
post.’
The FGD with community stakeholders suggested that 
this limited knowledge about TB negatively impacted 
engagement with TB services and treatment adherence. 
This was noted to potentially increase the likelihood of 
a delayed diagnosis, more advanced disease at presen-
tation and acquisition of DR- TB during treatment. The 
perceived lack of knowledge was predominantly felt to 
relate to suboptimal TB education, advocacy and polit-
ical commitment from health system and governmental 
leaders. Participants also reported that the current health 
education programmes are scarce and unable to reach 
poorer, educationally and socially marginalised commu-
nities with high TB risk.
Theme: facilitating treatment access through education about 
TB disease and advocacy about TB services, especially in remote 
communities
Across all the FGDs, participants described the need to 
raise community awareness on risk factors for TB, mode of 
TB transmission, and TB signs and symptoms. Community 
stakeholders particularly felt that future awareness- raising 
programmes would benefit by informing communities 
about available free TB diagnostic and treatment services 
in their local area and adding a component to reduce 
TB- related stigma. Further, NTP stakeholders stressed 
the importance of not only providing education but also, 
in the face of competing health beliefs, influencing atti-
tudes and promoting behavioural change.
Community stakeholders suggested that the govern-
ment should take responsibility for the development and 
implementation of intensive household- level and village- 
level awareness programmes using technology such as 
smartphone applications and social media. They also 
recommended broadcasting educational campaigns on 
television adapted from similar campaigns in the field 
of HIV (HIV ka sawal) and maternal care (Aama ko 
Maya) in Nepal. However, there was concern that infor-
mation transmitted through media could bypass vulner-
able, poor and marginalised populations. To overcome 
this, the group suggested innovative and interactive 
community- based approaches such as coordination with 
local women’s group- initiated self- help enterprises, street 
plays and engaging TB survivors as peer champions and 
educators to improve TB education. The involvement 
and ownership of TB education programmes by commu-
nity leaders, including volunteers, teachers and commu-
nity mobilisers, was also deemed important to achieve 
effective, decentralised delivery. Furthermore, the 
stakeholders acknowledged the essential role of health-
care provider- led education as part of a client–provider 
contract because people with TB need—and will follow—
advice from healthcare providers only when that advice 
is relayed sensitively and understood thoroughly. Never-
theless, people with TB indicated that both sensitisation 
and education from a trusted source were key to deliver 
education successfully and to enable and empower 
communities.
FGD with community leaders, 50–55 years age group, 
female: ‘We need to create [educational] groups attached to 
health centres and schools. Community and locally- elected leaders 
and teachers could give education to their communities and 
conduct TB awareness training and workshops.’
Figure 2 The inner white circle contains the key categories 
that influence tuberculosis (TB) service access and 
engagement, which are adapted from a WHO medication 
adherence framework (see the Methods section).22 The 
middle red circle indicates the main barriers identified for 
each category, which may threaten access to TB services. 
The outer green circle indicates the main facilitators 
(current or potential) for each category, which may enhance 
access to TB services. Barriers relating to ‘TB, health and 
basic education’, ‘social protection and nutrition’, and 
‘psychosocial’ were perceived by the project team to be 
modifiable by a household level socioeconomic intervention. 
Barriers relating to the ‘health system’ were perceived by 
the project team to be non- modifiable by a household- level 
socioeconomic intervention and are, therefore, separated 
from the other categories and represented by dotted lines. 
‘PPM’ as a health system barrier refers to the protracted 
and convoluted patient journey through public and 
private healthcare providers, which was reported as being 
associated with increased economic impact, especially 
related to out- of- pocket costs. The surrounding bidirectional 
arrows indicate the cross- FGD finding that adequate funding 
and advocacy, and political will and commitment were 
perceived as vital structural factors to enable the facilitators 
identified to overcome the barriers identified. DOTS, 
directly observed treatment short- course; DS- TB, drug- 
sensitive tuberculosis; FGD, focus group discussion; NTP, 
National Tuberculosis Programme; PPM, public–private mix. 
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Social protection and nutrition
Theme: social and economic barriers to accessing and engaging 
with TB diagnosis and treatment
Across FGDs, the participants reported food insecurity, 
high travel and food costs, and lost income as key barriers 
to accessing and engaging with TB diagnosis and treat-
ment (figure 2). The direct out- of- pocket costs of seeking 
TB diagnosis and engaging with DOTS at both public and 
private clinics, including food and transport, were raised 
repeatedly across FGDs as a significant barrier to timely 
diagnosis and medication adherence.
FGD with community leaders, 50- 55 years age group, 
female: ‘TB medicines are free but people also need money for 
two- way transportation and food. TB illness [and even] TB 
treatment can make people weak and nutrition is needed. How 
can people afford these [nutrition and transportation] costs?’
Nonetheless, patient journeys were repeatedly reported 
as long and convoluted, including a public–private mix of 
traditional medicine, pharmacies, local private healthcare 
providers and larger private clinics before reaching NTP 
diagnostic and treatment services (figure 2). As a result, 
TB- affected households incurred significant expenses.
FGD with people diagnosed with TB, 45- 50 years age 
group, male: ‘I visited all the pharmacies in my city, about 
15–17 medicals [pharmacies] overall. I used to buy pneumonia 
medicine and take it every time. TB was not initially identified. 
After a month without taking any medicines, TB was identified 
[at the government clinic]… The barrier is more financial. I 
spent approximately 1.7 lakhs [~1530 USD] for my treatment.’
Undernutrition and food insecurity were recognised as 
risk factors for TB and to contribute to suboptimal adher-
ence. Across FGDs, it was noted that many TB- affected 
households have insufficient resources to buy nutritious 
food. In addition, it was perceived that lack of education 
negatively impacted decision making related to nutrition 
to recover during TB treatment. In particular, commu-
nity leaders and people with DR- TB raised concerns 
that the current monthly governmental nutrition allow-
ance was insufficient to obtain nutritional food, such as 
meat and fruits, which is often recommended by health-
care providers. Female participants with TB mentioned 
a trade- off between out- of- pocket expenses to purchase 
the recommended nutritional food vs transportation 
expenses associated with DOTS at TB clinics.
Lost income was identified in the majority of FGDs as a 
notable barrier to accessing diagnosis and engaging with 
TB care, which compounded the economic impact of out- 
of- pocket travel and food costs. People with TB expressed 
guilt and stress related to having to stop work following 
their TB diagnosis and the fear of not getting employ-
ment again. Female participants described the impact as 
hardest on poorer populations, women working in the 
fields, and labourers, who lack the free time required to 
go to the health facility for daily DOTS, especially when 
opening hours and prime labouring hours coincide.
Community stakeholders and people with TB frequently 
cited that TB- affected households use coping strategies 
to mitigate the economic impact of TB, most commonly 
to obtain funds to buy food. Selling assets, such as live-
stock, milk, land and jewellery, was reported as a predom-
inant coping strategy. However, it was noted that some 
vulnerable patients were so poor that they have nothing 
to sell. Other coping strategies mentioned included 
borrowing money, formally and informally, which led to 
further economic hardship and difficulties maintaining 
adherence.
FGD with people diagnosed with TB, 25- 30 years age 
group, male: ‘I had difficulties [to pay money to access TB 
services] and wasn’t able to go [to the clinic] for a month. I had 
to borrow money from my friends.’
Theme: facilitating treatment adherence by people with TB through 
nutritional and/or economic support
Participants discussed the need for social protection 
including insurance, transportation allowance and nutri-
tional support for TB- affected people (figure 2).
The potential for economic support to improve nutri-
tion, defray travel and other out- of- pocket costs, and 
increase TB treatment success, was raised in all FGDs. It 
was acknowledged, particularly in FGDs with NTP stake-
holders and people with TB, that the government of 
Nepal provides Rs 3000/month (~US$ 27 for ambulatory 
MDR- TB cases and Rs 1000/month (~US$8) for those 
staying at DR- TB hostels. While the NTP stipulates that 
this is intended as nutritional and/or transport allow-
ance, participants noted that how the cash is spent is 
not monitored. In addition, issues were raised with this 
existing transfer scheme, including delays in delivery of 
the allowance.
FGD with CSO, 45- 50 years age group, male: ‘The most 
important question is when to give the allowance. It would be 
better in the first phase [of treatment] because it is [most] valu-
able at this time when one needs it most.’
There was further debate concerning whether cash or 
nutritional support was most appropriate. Some commu-
nity stakeholders raised concerns regarding misuse of 
cash payments (eg, to buy alcohol) and suggested that 
it would be preferable to provide nutritious food such 
as milk, ghee (local butter), meat and eggs. However, 
females with TB perceived that any cash received would 
nevertheless be spent on food, primarily staple foods such 
as rice, to feed their household.
Finally, it was perceived across FGDs that any nutritional 
or economic support should either be provided to all or 
stratified by need rather than TB drug resistance profile.
FGD with people diagnosed with TB, 30- 35 years age 
group, male: ‘The government should provide nutritious food 
based on the economic status of patients. Drug- sensitive patients 
should also be provided with an allowance based on their level of 
poverty.’
Psychosocial
Theme: psychosocial barriers to treatment adherence
Across all FGDs, stigma was perceived to be a signifi-
cant barrier to seeking, accessing, and engaging with 
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described feeling discriminated against, mistreated, 
isolated or hated. They reported perceptions or instances 
of people talking behind their back or remaining phys-
ically distanced. Participants of the FGD with commu-
nity stakeholders shared that sometimes people with TB 
experienced extreme negative behaviour such as phys-
ical or psychological mistreatment from their own family 
members. The situation was discussed as being even more 
pronounced for young married females because of a lack 
of personal agency within their husband’s family. While 
this stigmatising behaviour towards people with TB was 
reported to occur across socioeconomic groups, partic-
ipants described that a ‘blame and shame culture’ was 
prevalent among family members belonging to groups 
perceived as ‘higher’ in the caste related, social hierarchy. 
In alignment with this assertion, community mobilisers 
mentioned that lack of social and family support can 
cause people to conceal their TB status and not adhere to 
or complete TB treatment.
Reports of stigmatising behaviour were not limited to 
the community and family members. Perceived negative 
behaviour of healthcare providers towards people with 
TB was noted across FGDs as an issue that compounded 
self- stigma and led to a breakdown of trust within the 
client–provider relationship. Although participants felt 
that, generally, enacted stigma had decreased in Nepalese 
communities, FGDs with people with TB and community 
stakeholders shared that people still fear TB disease, espe-
cially in rural villages.
FGD with people diagnosed with TB, 30- 35 years age 
group, male: ‘People may know they have symptoms of TB but 
are too ashamed to go to the health facilities. People can’t say 
out loud that they have TB. TB is regarded as a big disease and 
people get criticized for having it. The community perceives a TB 
patient differently than a normal person due to lack of aware-
ness. That’s why it’s difficult to end TB.’
People with MDR- TB reported profound psychoso-
cial impact including anxiety and isolation, especially 
during the first months of treatment. Depression, suicidal 
ideation and shame related to stigma and also well- 
recognised side effects of MDR- TB medications were 
mentioned.23
FGD with people diagnosed with MDR- TB, 45- 50 years 
age group, male: ‘I wanted to die. One of my friends [with 
MDR- TB] committed suicide after 16 months [of treatment].’
Theme: Mutual or social support as a facilitator to treatment 
adherence
Social support from family and friends was perceived as 
a facilitator to adhering to TB treatment and becoming 
cured (figure 2). This included visiting, spending time 
with and showing affection towards people with TB to 
demonstrate solidarity and reduce feelings of isolation.
People with TB also shared the importance of mutual 
support beyond family and friends, including the wider 
community, leaders, elders and other important local 
figures. The participants believed that this kind of support 
would help people with TB to cope and reflected the 
close communities and rich socio- cultural values inherent 
to Nepalese culture.
FGD with people diagnosed with MDR- TB, 40- 45 years 
age group, male: ‘My friends and the people in my village told 
me ‘TB is a normal disease and encouraged me that, if I took my 
medicine, I’d be alright.’
Interactions and consultations with healthcare providers 
were also seen as opportune occasions to provide educa-
tion and counselling to address the psychological impact 
of TB. FGD with community stakeholders raised the 
perceived importance of healthcare providers simply 
recognising, acknowledging and being understanding of 
patients’ fears, concerns and expectations. While health-
care provider- led counselling on medication adherence 
was noted to be commonplace at treatment initiation, 
counselling patients with TB about TB- related fear, 
stigma, depression and anxiety was broadly overlooked. It 
was noted that integration of medication and psycholog-
ical counselling by healthcare providers could be a suit-
able method to deliver clear and open information about 
stigma and discrimination, which could improve TB treat-
ment adherence and completion rates and potentially 
support mental wellness and empowerment.
DISCUSSION
This qualitative study generated new evidence regarding 
barriers and facilitators to accessing and engaging with TB 
services in Nepal. Multisectoral stakeholder participants 
highlighted that the barriers were predominantly related 
to the poor socioeconomic conditions of people with TB, 
including lack of education and endemic poverty. The 
findings showed that the costs of care- seeking and clinic- 
based DOTS can further compound poverty and, when 
combined with psychological impacts including stigma 
and anxiety, were perceived to negatively influence access 
to TB services. Participants cited multiple potential socio-
economic interventions, both integrated and discrete, 
including TB education, economic, nutritional and social 
support, to mitigate catastrophic costs of TB- affected 
households and support people with TB to get cured.
Knowledge and awareness about TB
Low education levels and limited awareness of TB are 
associated with delays in healthcare seeking.24–26 A study 
in Nepal showed inadequate knowledge of TB was asso-
ciated with increased likelihood of consulting traditional 
healers, resulting in TB diagnostic delay.27 Our findings 
are also similar to other studies that suggested knowl-
edge about TB was limited in poor, marginalised and/
or rural communities in Nepal.8 28 This implies that any 
existing TB education and advocacy programmes may 
not be reaching crucial, high- risk target groups and new 
approaches are required if Nepal is to end TB.
Educational support interventions that enhance 
knowledge about TB transmission, symptoms, treatment 
and prevention, are important contributory factors in 
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in diverse settings.27 29 30 In India, the Global Fund- 
supported advocacy, communication and social mobil-
isation project, ‘Axshya’, has made progress towards 
reaching underserved groups through intense commu-
nity outreach and education.31 FGD participants in our 
study cited a dearth of awareness- raising interventions 
and campaigns in recent years in Nepal. Previously, similar 
campaigns focused on TB awareness through door- to- 
door visits, health promotion at health facilities or educa-
tional outreach into communities. Such campaigns were 
perceived to increase knowledge on TB, advocate for free 
TB services and empower communities to make informed 
choices. As highlighted by participants, in addition to 
commonly used platforms such as leaflets, radio and 
television, future educational campaigns in Nepal would 
benefit from using technology such as mobile phones—
which are used by over 90% households in both urban 
and rural areas32—or, where appropriate, social media.
Psychosocial impact
Of the perceived psychosocial barriers to accessing TB 
diagnosis and care in Nepal, stigma predominated. Partic-
ipants mentioned feelings of guilt among people with 
TB, fear of disclosure and experience of discrimination. 
This mirrors findings from diverse settings, which show 
that experiences of stigma are highly prevalent among 
people with TB and can impede access to TB services.33 
For example, in Zambia, a cohort study showed that antic-
ipated and enacted stigma of people with TB resulted in 
delayed diagnosis, poor treatment adherence, reduced 
quality of life and represented a distinct challenge to 
successful screening of their household contacts.34
It was notable that people with MDR- TB reported 
severe negative psychosocial impacts of their illness. 
These included profound feelings of anxiety, isolation 
related not only to their diagnosis but also to physical 
distance from their families, and recognised side effects 
of certain MDR- TB medications (eg, cycloserine) such 
as depression and despair.35–37 Participants perceived an 
association between the psychosocial impact of MDR- TB 
and the potential for non- adherence to long, arduous 
treatment regimens including injectable agents. Discus-
sion across FGDs suggested that existing medication 
adherence counselling delivered by NTP staff at treat-
ment initiation would be a suitable platform on which to 
integrate complementary psychosocial counselling about 
overcoming TB- related stigma and addressing ill mental 
health.
Economic burden of TB
The economic impact of accessing TB diagnosis and 
care was perceived to be severe. This was mainly due 
to high costs associated with transportation to clinics, 
maintaining adequate nutrition and time and income 
loss. Participants with MDR- TB indicated that there was 
delay or unavailability of the NTP’s financial assistance 
scheme during their treatment. The financial impact of 
belonging to a household affected by TB was cited in 
FGDs as forcing households to resort to coping strategies 
such as taking out loans, using savings and selling assets. 
These findings are in line with the rapidly growing global 
body of evidence relating to the economic burden of 
TB. Such findings suggest that coping strategies remain 
common and only limited progress has been made 
towards the WHO target of ‘zero TB- affected families face 
catastrophic costs by 2020’.1 38 TB Patient Costs Surveys 
conducted in various LMICs have demonstrated that a 
substantial proportion of TB- affected households incur 
catastrophic costs, which can push them into further 
impoverishment and contribute to adverse TB treatment 
outcomes.6 39–44 Studies demonstrated that more than 
60% of TB- affected households in Nepal incurred cata-
strophic costs6 7 and stark economic impact.27 45–47
Although this study focused on barriers amenable to 
interventions at the household level rather than health 
system level, our findings showed that when TB diagnosis 
and care were sought from both the public and private 
sector, patient pathways to TB diagnosis and care were 
protracted and their costs, especially out- of- pocket costs, 
escalated (described in detail in online supplemental 
file 2). This finding is consistent with the findings of 
systematic reviews from Nepal, India and Uganda,48–54 
which also highlighted that interventions to strengthen 
public–private partnerships can streamline diagnostic 
and referral pathways and potentially increase TB noti-
fications to the NTP. Studies in India and Vietnam have 
demonstrated enhanced engagement with private phar-
macies and medical practitioners by providing them 
subsidies directly or through intermediary agencies for 
every notified case.55 56 This could be a potential strategy 
to improve access to TB care in Nepal, where approxi-
mately 20% people with TB receive paid treatment from 
the private sector.57
Social and economic support
To address the psychosocial and economic impact of TB 
and improve TB cure and prevention rates, our find-
ings imply a need for both social and economic support. 
This is supported by the results of studies in Nepal and 
other LMICs, which showed that providing both coun-
selling and economic assistance to people with MDR- TB 
improved cure rates.9 58–60 However, it must be noted that 
a significant proportion of people with DS- TB in Nepal 
experience enduring psychological, social and economic 
impacts of TB but receive no additional support.6 7 12 
In line with a study from Ethiopia,61 our findings also 
suggest that the timing of provision of financial support is 
important. Participants advocated for early cash support 
delivery in the initiation phase of treatment when they 
perceived it to be needed most. Involvement of family 
members and peers in such interventions was also noted 
by participants as a vital aspect of support to complete 
TB treatment. This has also been reported in a system-
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A well- designed socioeconomic support intervention 
would ideally be tailored or stratified to the individual 
or household needs of a person with TB and include 
overlapping elements such as increasing knowledge, 
awareness- raising, cost mitigation (eg, through cash 
transfers or transport vouchers) and stigma- reduction 
activities (eg, mutual support, peer groups, enhanced 
medication counselling sessions), integrated into existing 
TB services.63 64 However, it must be acknowledged that 
such an intervention would need to balance stratification 
with feasibility and pragmatism.
Strengths and limitations
Our study fills an important gap in knowledge about 
household- level socioeconomic barriers to accessing TB 
services in Nepal and expanded on perceived facilitators 
and enablers to overcome these barriers. A major strength 
of the study methods was the trustworthiness and validity 
harnessed by garnering perspectives of the diverse study 
participants.65
The study has several limitations. As the participants 
were predominantly from Terai plains districts the find-
ings, therefore, should be cautiously applied in other 
settings or countries. Nevertheless, we described the 
study setting to improve transferability. Second, partici-
pants from NGOs and healthcare professionals working 
with the NTP were over- represented within the partici-
pant cohort. However, we tried to strike a suitable balance 
by including the views of people with TB and commu-
nity groups, which historically have been overlooked in 
similar research. FGDs consisted of limited women partic-
ipants. We minimised the issue by specifically describing 
the female participants’ viewpoint in the analysis. Simi-
larly, there was no participation of people diagnosed 
with TB in private sectors or those who had been lost to 
follow- up who are the vulnerable to restricted access to 
TB services and poor outcomes. Their engagement would 
enable us to fully understand the most important barriers 
to care.39 64
CONCLUSION
There are multiple socioeconomic barriers to accessing 
and engaging with TB services in Nepal. TB education 
and advocacy, economic support and psychosocial coun-
selling integrated with medication adherence counselling 
could address these barriers and potentially reduce stigma, 
mitigate TB- related costs and improve TB treatment 
outcomes. These elements are now being incorporated 
into the design of a locally appropriate socioeconomic 
support intervention for TB- affected households for pilot 
implementation in Nepal.
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